.jpg)
Federal health leaders are signaling that artificial intelligence is entering a new phase in U.S. healthcare. The question is no longer whether AI belongs in clinical care, but how quickly it can be deployed safely, governed responsibly and integrated into everyday workflows. Federal agencies are aligning on a comprehensive AI strategy focused on innovation, infrastructure, and leadership to ensure safe and effective deployment.
A coalition of 26 states is suing the Trump administration over its rollout of Medicaid work requirements. In the lawsuit, the states seek to challenge provisions in the Centers for Medicare & Medicaid Services' recently-finalized rule establishing guardrails for the work requirements implementation.
Anthropic Launches Claude Science to Court Pharma Ahead of IPO
Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work. Claude Science is designed to pull together the databases, lab tools and computing power researchers normally juggle across dozens of programs. Researchers can give the platform a single instruction, like asking it to screen for a promising drug compound, and it will carry out the analysis, run the necessary computing tasks and return results on its own.
CMS launches the Medicare GLP-1 Bridge — but 4 questions linger
CMS is rolling out the Medicare GLP-1 Bridge program — a demonstration designed to give eligible Medicare Part D beneficiaries access to certain GLP-1s at a fixed monthly cost — July 1. The program runs from July 1, 2026, through Dec. 31, 2027. Throughout the 18 months, CMS aims to gather data on how expanded GLP-1 access affects health outcomes, utilization and program operations. Manufacturers are providing GLP-1s at a net price of $245 per month. Medicare beneficiaries will shoulder $50, while CMS will cover $195. Foundayo, Wegovy and Zepbound are available through the program.
Coalition Calls for Long-Term Accountable Kidney Care Model
A coalition of provider organizations focused on kidney care is calling on the Center for Medicare & Medicaid Innovation (CMMI) to create a long-term, stable accountable kidney care model. The current demonstration model, Comprehensive Kidney Care Contracting (CKCC), is slated to end in 2027. In one paper, the coalition argues that the CKCC model shows stronger savings potential than early evaluations suggest while delivering significant quality improvements.
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn